ONDREJ HRDY

Dr. ONDREJ HRDY

Faculty of Medicine, Masaryk University and University Hospital, Brno, Czech Republic
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 January 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
OHONDREJ HRDY
ONDREJ HRDY
KVKamil Vrbica
Kamil Vrbica
MKMarek Kovar
Marek Kovar
TKTomas Korbicka
Tomas Korbicka
RSRadka Stepanova
Radka Stepanova
RGRoman Gal
Roman Gal
Loss of muscle mass occurs rapidly during critical illness and negatively affects quality of life. The incidence of clinically significant muscle wasting in critically ill patients is unclear. This study aimed to assess the incidence of and identify predictors for clinically significant loss of muscle mass in this patient population. This was a single-center observational study. We used ultrasound to determine the rectus femoris cross-sectional area (RFcsa) on the first and seventh day of ICU stay. The primary outcome was the incidence of significant muscle wasting. We used a logistic regression model to determine significant predictors for muscle wasting. Ultrasound measurements were completed in 104 patients. Sixty-two of these patients (59.6%) showed ≥ 10% decreases in RFcsa. We did not identify any predictor for significant muscle wasting, however, age was of borderline significance (p = 0.0528). The 28-day mortality rate was higher in patients with significant wasting, but this difference was not statistically significant (30.6% versus 16.7%; p = 0.165). Clinically significant muscle wasting was frequent in our cohort of patients. Patient age was identified as a predictor of borderline significance for muscle wasting. The results could be used to plan future studies on this topic.Trial registration: ClinicalTrials.gov NCT03865095, date of registration: 06/03/2019.

13 April 2021 in American Journal of Case Reports
Verified
Journal Article
Open access
RGRoman Gal
Roman Gal
IZIveta Zimova
Iveta Zimova
HAHelena Antoni
Helena Antoni
PMPetra Minarcikova
Petra Minarcikova
PVPavel Ventruba
Pavel Ventruba
OHONDREJ HRDY
ONDREJ HRDY
Delivery of a Healthy Baby from a Brain-Dead Woman After 117 Days of Somatic Support: A Case Report - Article abstract #930926

23 November 2020 in Trials
Verified
Journal Article
Open access
PDF file
OHONDREJ HRDY
ONDREJ HRDY
KVKamil Vrbica
Kamil Vrbica
ESEva Strazevska
Eva Strazevska
PSPetr Suk
Petr Suk
LSLenka Souckova
Lenka Souckova
RGRoman Gal
Roman Gal
Background: Enteral nutrition is part of the treatment of critically ill patients. Administration of enteral nutrition may be associated with signs of intolerance, such as high gastric residual volumes, diarrhea, and vomiting. Clinical trials regarding the effects of the mode of administration of enteral nutrition on the occurrence of these complications have yielded conflicting results. This trial aims to investigate whether the mode of administration of enteral nutrition affects the time to reach nutritional targets, intolerance, and complications. Methods: COINN is a randomized, monocentric study for critically ill adult patients receiving enteral nutrition. Patients will be randomly assigned to two groups receiving (1) continuous or (2) intermittent administration of enteral nutrition. Enhancement of enteral nutrition will depend on signs of tolerance, mainly the gastric residual volume. The primary outcome will be the time to reach the energetic target. Secondary outcomes will be the time to reach the protein target, tolerance, complications, hospital and ICU lengths of stay, and 28-day mortality. Discussion: This trial aims to evaluate whether the mode of application of enteral nutrition affects the time to reach nutritional targets, signs of intolerance, and complications. Trial registration: ClinicalTrials.gov NCT03573453. Registered on 29 June 2018

27 September 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
FKFilip Keller
Filip Keller
HAHelena Antoni
Helena Antoni
PMPetra Minarcikova
Petra Minarcikova
OHONDREJ HRDY
ONDREJ HRDY
RGRoman Gal
Roman Gal
Mucormycosis is an opportunistic infection affecting mainly immunocompromised hosts. Infection in immunocompetent patients is rare, but may occur typically in trauma or burn victims. We report on a previously healthy young man suffering devastating trauma from an agricultural accident with the subsequent development of a multifocal mucormycosis. Diagnosis was achieved by cultures obtained from non-healing wounds, some of them even covered by a macroscopic mold formation. Specific treatment was initiated soon after the preliminary results indicated mucormycosis. Aggressive surgical therapy, with concomitant use of systemic posaconazole and topical amphotericin B in a combination treatment, led to the elimination of the fungal infection. The remaining deep tissue defects were consequently reconstructed by a muscle flap and skin graft autotransplantation with a good overall outcome, which would not have been possible without the complete remission of mucormycosis. This case study presents the successful use of a combination treatment with systemic posaconazole and topical amphotericin B and underlines the importance of timely and aggressive surgical therapy.

1 January 2023 in Journal of Critical Care Medicine
Verified
Journal Article
Open access
PDF file
GRGal Roman
Gal Roman
OHONDREJ HRDY
ONDREJ HRDY
KVKamil Vrbica
Kamil Vrbica
JHJan Hudec
Jan Hudec
AMAndrej Mrlian
Andrej Mrlian
MSMartin Smrcka
Martin Smrcka
Introduction: Management of traumatic brain injury (TBI) requires a multidisciplinary approach and represents a significant challenge for both neurosurgeons and intensivists. The role of brain tissue oxygenation (PbtO2) monitoring and its impact on posttraumatic outcomes remains a controversial topic. Aim of the study: Our study aimed to evaluate the impact of PbtO2 monitoring on mortality, 30 days and 6 months neurological outcomes in patients with severe TBI compared with those resulting from standard intracranial pressure (ICP) monitoring. Material and methods: In this retrospective cohort study, we analysed the outcomes of 77 patients with severe TBI who met the inclusion criteria. These patients were divided into two groups, including 37 patients who were managed with ICP and PbtO2 monitoring protocols and 40 patients who were managed using ICP protocols alone. Results: There were no significant differences in demographic data between the two groups. We found no statistically significant differences in mortality or Glasgow Outcome Scale (GOS) scores one month after TBI. However, our results revealed that GOS scores at 6 months had improved significantly among patients managed with PbtO2; this finding was particularly notable for Glasgow Outcome Scale (GOS) scores of 4–5. Close monitoring and management of reductions in PbtO2, particularly by increasing the fraction of inspired oxygen, was associated with higher partial pressures of oxygen in this group. Conclusions: Monitoring of PbtO2 may facilitate the appropriate evaluation and treatment of low PbtO2 and represents a promising tool for the management of patients with severe TBI. Additional studies will be needed to confirm these findings.

1 April 2021 in Minerva Anestesiologica
Verified
Journal Article
Closed access
OHONDREJ HRDY
ONDREJ HRDY
KVKamil Vrbica
Kamil Vrbica
MKMarek Kovar
Marek Kovar
TKTomas Korbicka
Tomas Korbicka
RGRoman Gal
Roman Gal
Article: Intra- and interobserver agreement of rectus femoris cross-sectional area in critically ill patients - Minerva Anestesiologica 2021 April;87(4):494-5 - Minerva Medica - Journals